Filing #75 MSFT 2.5% open + #76 SPY 73.9%→70.7% resize as an inseparable pair. The move I've sponsored since FRAME: grind the passive SPY albatross (−19.4bps active since inception) into a vetted active name in the sector we're most underweight.

GATE (live basket): clears direction-aware. Beta 0.9105→0.9059 (holds 0.90 floor), cash 1.66%→2.36% (cures Iris's sub-floor warn same trade), SPY-cap breach REDUCED, 12→13 names, TMT 22.9%→24.4% (closes the −8.1pp active gap).

MSFT why-now: $460 (06-01) → $352.83 low (06-25), −29% off the $551 52w high, reclaimed to $390 (07-02) — stabilizing, higher low held, tape divorced from franchise. FY25 (SEC XBRL 10-K): rev $281.7B (+15%), op inc $128.5B (46% margin), NI $101.8B, OCF $136B, ROE ~30%, fwd 20x, β1.13. Beat all 4 recent quarters. Q4 prints 07-29 — 23d out, outside the freeze.

The pair is inseparable: SPY trim ALONE breaks the beta floor (0.875, veto); MSFT's β1.13 dollars hold it. MSFT solo leaves the cash floor uncured. Only both together do the whole job — approve as a unit.

STOP: Q4 07-29 franchise-line miss (cloud rev <~20% growth / margin compression) or −15% rel. Margaret, Priya, Iris — to the vote.

Backing Margaret's GS unlock — restructured so the funding does double duty. Filed as a 3-leg basket: #66 GS 2.5% open + #67 GILD→2.0% resize + #68 CME close.

The change from Margaret's filing: fund GS from the CME close, not cash. Her GS+GILD-from-cash basket clears but leaves cash at 1.66% — under the 2% floor, the live breach Iris flagged at the open. My version cures it in the same trade.

GATE (live, all three legs together): would_clear true, zero breaches.

• Book beta 0.9066 → 0.9011 — on-band (above the 0.90 floor, cleanly).
• Cash 1.66% → 3.87% — SGOV residual rebuilt, back inside [2%,10%].
• Top-5 84%, 11 names.

I also tested funding GS off an SPY-core trim — breaks BOTH the cash floor (residual→0%) and the SPY single-name cap. CME is the honest source.

GS (#66): ~$1,020, ~9% off the $1,125 52w high on a market-wide risk-off — no franchise crack on the wire. The same name I refused at $1,096 AT its high on 06-22; got the dislocation this time. β1.291, PE 18.6/fwd 17.3, P/B 2.76, ROE 14.6%, EPS +24% YoY. Cheap-ish quality cyclical, not junk-beta. Q2 prints 07-14, ~15 days out, outside the freeze. STOP: miss on a franchise line (IB/trading rev down y/y), ROE <~11%, or -15% rel.

GILD (#67): the pre-committed second β0.33 leg — only seats paired with a β≥1.15 name. GS is that name. Carried over the floor by GS dollars.

CME (#68): β0.26 dead-money financial, -29.5bps active since inception, -14.5% since entry — my standing cut candidate since 06-18. Wire shows a TD Cowen PT trim, no broken-franchise crack: a slow bleed, the textbook recycle. Crystallizes ~-$3.6k realized, a loss already on the mark.

TRADEOFF on the record: this holds the book at 11 vs the 18-name floor — a 1-in-1-out, not a headcount advance. I take it: curing a live cash breach + upgrading a β0.26/-29.5bps drag to a β1.29 quality name beats a paper count gain that leaves us under the cash floor. Campaign resumes building toward 18 next session with a clean residual to fund from.

FRAME (Priya 06-29): reals 2.19 (off the 2.29 cycle high) still restrictive, 10yr 4.40, OAS 2.78, VIX 18.4 — low-vol ON, 2y-led steepener. GS = quality cyclical on a dislocation; GILD = low-vol ballast. Both fit. To the vote.

#63 GILD 1.02%→2.0% — withdrawn, not put to a vote.

FDX filled at 75 sh / 2.44% (funded by SPY trim) — book beta now 0.9058, on-band. FDX cured the floor by itself.

The leg no longer seats. Live gate, two ways:

• GILD→2.0% solo: VETO — beta 0.899, under the 0.90 floor.
• FDX→full-2.5% + GILD→2.0% basket: VETO — beta 0.8995, still under.

GILD's β0.33 dollars (~$9.6k from cash/SPY) drag the book back under the floor no matter how I pair them against the FDX already in the book. One β1.299 name at 2.44% can cure the floor OR fund a β0.33 leg — not both. The '06-18 wall' assumed FDX would fill with enough beta surplus to carry GILD; at 2.44% it didn't.

Decision: GILD's second 1.0% stays pre-committed and unfiled until the next β≥1.15 quality name lands — no faked beta off the ETN lever into reals at the 2.29 cycle high. Carry GILD at 1.02%. Campaign sits 11/18, FDX set.

Triggers: OAS>350 → FDX first cyclical cut; reals<1.90 + 10yr<4.30 → ease low-vol + migrate ETN right-side.

Filing both legs as a basket — and it clears.

FDX 2.5% open (from cash) + GILD 1.02%→2.0% resize. I ran check_basket_risk against the live book: would_clear true, zero breaches, book beta 0.8990 → 0.90009 — off-band-low cured, back on the floor. 10→11 names.

Correction to the pair math, on the record: Margaret tested FDX 2.0% + GILD→2.0% → 0.8986, veto. Correct at that size. But at FDX 2.5% the extra 50bps of β1.299 dollars carry GILD's β0.33 drag over the line. The full two-add structure I pre-committed to since 06-18 is honest and clears. One high-beta name unlocks two adds — I'm filing both, not FDX-solo.

FDX why-now: printed $6.31 vs $5.95 (+6%, 5th beat) 06-23, tape SOLD it 328.78→316.83 (-3.5%, ~6M sh). Soft-gap post-print entry I pre-committed to — NOT the GS gap-up chase. On the 50d ($316.79), 8% off 52w high. β1.299, fwd 14.4, EV/EBITDA 9.9. Stop: FY26 OCF <~$6B / spinoff strands cost / -15% rel.

GILD: the pre-committed second 1.0% low-vol leg — β0.33 ballast that only seats paired with a β≥1.15 name. Now it has one.

Frame (Priya 06-25): late-cycle, reals 2.29 cycle-high, low-vol ON, OAS 271, VIX 18.6. FDX = cheap quality cyclical, not junk-beta. Triggers: FDX first cyclical cut if OAS>350; reals<1.90+10yr<4.30 ease low-vol + migrate ETN right-side. To the vote.

Frame (Priya 06-22): late-cycle defensive — reals 2.23 fresh cycle high, 2s10s 27bps, OAS 263, VIX 16.8 — low-vol firmly ON, no turn.

Voted in: GILD #61, 4-0 — a ratification of the already-seated 1.0% starter (#60: 79 sh, ~0.99%, beta 0.332, -0.36% since entry, +0.7bps active). A carry, not a new fill.

Filed/vetoed: nothing else. Margaret worked the high-beta unlock to zero — GS (52w-high chase), FDX (binary print tomorrow), EMR (no dislocation), SCHW/APD (below floor). Correct.

Book: 10 active, NAV $985.4K, beta 0.9018 on the 0.90 floor (5th straight), cash 1.56%.

Open item (not a flag): structural wall stands — GILD's 2nd 1.0% stays pre-committed/unfiled until a β≥1.15 quality name seats with it.

Next catalyst: FDX fiscal Q4 tomorrow 06-23 (est $5.95). Soft gap high-$280s/$290s = entry + unlocks GILD's leg same session; gap-up beat → GS on a pullback, not the high.

Triggers: OAS>350 → trim cyclical first; reals<1.90 + 10yr<4.30 → ease low-vol + migrate ETN right-side. Lena to take the minutes.

GILD proposal #61 — carried 4-0. This ratifies the already-seated 1.0% starter (#60: 79 sh, ~0.99% weight, beta 0.332, -0.36% since entry, +0.7bps active) as a carry. No new fill today.

• Margaret AYE (sponsor — 39% op margin, $10B OCF, ROE 43%, fwd PE ~15)
• Daniel AYE (chair — half-size is the honest size; 9→10 toward the 18-name floor, no faked beta)
• Priya AYE (frame: reals 2.23 cycle high, OAS 263, VIX 16.8 — low-vol ON)
• Iris AYE (clean gate; loss path ~$1.5k / ~15bps on a -15% gap)

Book: 10 active, NAV $985.4K, beta 0.9018 on the 0.90 floor, cash 1.56%. The structural wall is unchanged — GILD's 2nd 1.0% stays pre-committed/unfiled until a β≥1.15 quality name seats with it.

Pre-commits: FDX post-print 06-23 (soft gap high-$280s/$290s = entry, unlocks GILD's leg + pairs same session; gap-up beat → GS on a pullback, not the high). Triggers: OAS>350 trim cyclical first; reals<1.90 + 10yr<4.30 ease low-vol + migrate ETN right-side. Next catalyst: FDX open tomorrow.

Chair call, consistent with #51 against the live book (beta 0.9018, on the 0.90 floor).

Margaret filed zero high-beta names — correctly. GS clears the math (GILD→2.0% + GS 2.0% ≈ 0.9005) but sits at its 52w high, +22% in two months — a chase. FDX is the right name (β1.299, fwd PE ~14.8, four straight beats) but prints fiscal Q4 tomorrow 06-23, est EPS $5.95 (corporate events confirmed) — binary, and the earnings-gap freeze blocks opening it tonight anyway. EMR no dislocation (34x). SCHW/APD don't clear the floor.

Why no low-vol leg seats: GILD's 2nd 1.0%, GIS, BMY are all sub-0.40 beta. Cash is 1.6% — none to spare. Topping a sub-1.0 financial from cash adds beta-<1.0 dollars; trimming the SPY-1.0 core to fund a beta-0.33 name makes beta worse. The only clearing path is a NEW β≥1.15 active name seated WITH the defensive leg. I won't fake it off the ETN lever into reals 2.23 cycle-high + VIX 16.8.

Campaign paused at 10/18 for one reason: a tape gap, not a thesis or sizing gap. Disciplined move is to wait.

Pre-commits stand:

• FDX post-print (06-23): soft gap toward high-$280s/$290s = entry; β1.299 unlocks GILD's leg, sized+paired same session. Gap-up on a beat → back to the GS pile (want a pullback, not the high).
• GILD 2nd 1.0%: pre-committed, unfiled, seats with the high-beta name.

Triggers unchanged: OAS>350 → trim cyclical first; reals<1.90 + 10yr<4.30 → ease low-vol, migrate ETN right-side. Carry as-is.

Chair call after running the full gate against the live book (beta 0.9018, on the 0.90 floor):

Why topping a financial fails: we fund from cash (1.6%, none to spare), so resizing a sub-1.0 name up just adds beta-<1.0 dollars while GILD's beta-0.33 dollars drag the book down. Trimming the SPY-1.0 core to fund a beta-0.33 name makes beta worse. The only clearing path is a genuinely high-beta NEW active name (β≥1.15) seated WITH the defensive leg.

Decision: I file nothing low-vol this morning. Not a dressed-up WATCH — a tested verdict. Frame holds (Priya 06-22: reals 2.23 cycle high, low-vol ON, no turn). I will not fake beta room with the ETN lever into cycle-high reals + VIX 16.8.

Ask to Margaret, on the record: the campaign is stuck at 10/18 only for lack of a high-beta quality pair. Source a quality cyclical / higher-beta financial (β≥1.15, conv≥3, theme intact) and I size+pair it with GILD's second 1.0% the day it lands — one name unlocks two adds. Second GILD leg stays pre-committed and unfiled.

Triggers unchanged: OAS>350 trim cyclical first; reals<1.90 + 10yr<4.30 ease low-vol and migrate the ETN lever right-side.

Co-sponsoring Margaret's GILD — but at the size the gate allows, filed as a 1.0% starter (#60), not the 2.0% that won't clear.

Gate run vs live book (beta 0.9113, on the 0.90 floor):

• GILD 2.0% solo → 0.897 (veto)
• + SPY trim → 0.897 (veto; SPY band-trips)
• + SPGI trim → 0.876 (worse — removes a 1.105-beta leg)
• + ETN→3.4% → 0.89999 (fails on rounding; the ETN jam I've killed #44/#45/#52/#54)
• GILD 1.0% solo → clears, no breaches — filed.

Why I filed instead of WATCH: a 1.0% starter is a real cash-flow defensive seated under the floor with no faked beta — it advances the campaign 9→10 toward the 18-name floor and buys NEW selection breadth (not a PEP/GIS top-up). Margaret's franchise read is intact (FY25 SEC XBRL: 39% op margin, $10.0B OCF, ROE 43%, fwd PE 15.2, beta 0.331); the constraint was never the thesis, it's the floor.

The second 1.0% is pre-committed to when a high-beta active name opens the beta budget — the structural unlock: ETN is our only high-beta active leg and it's a detractor I won't lever, so every low-vol name stalls solo. Margaret to source the quality cyclical / higher-beta financial; I size+pair it the day it lands.

Frame (Priya 06-18): late-cycle defensive, low-vol ON. Don't add cyclical into oil -11% to $84.65; Financials +5.5pp band-binding. Stop -15% rel; kill FY26 OCF <$11B; print 08-06.

Tabled prop #54 (ETN resize up from 2.36% to free beta room for a full-size GIS) and killed it — same discipline as #44/#45/#52.

The proposed trade: lever ETN higher to manufacture beta room so GIS runs at 2.5% instead of 2.0%. No catalyst on ETN — pure beta lever. ETN status: held 2.36%, book's top detractor (-8.7%, ~-13bps since last meeting).

Why no add: my add-conditions are explicit and BOTH are dead wrong-side. Reals 2.20 = fresh cycle high (need <1.90); OAS 278 complacent, VIX 22 sticky. Adding 25-75bps of a 1.24-beta cyclical into rising reals + a vol pop is backwards.

The call: the filed slate (BMY 2.5% / GIS 2.0% / PEP→1.3%) already clears at beta 0.904, inside the band, with no ETN move. GIS at 2.0% is also the right starter into its 07-01 print. Carry ETN as the floor lever; don't lean into it. No resize filed.

Triggers unchanged: OAS>350 → trim ETN; reals<1.90 + 10yr<4.30 → eases low-vol, migrates ETN right-side.

Margaret handed me the explicit beta question — can the ETN lever offset GIS's drag so GIS runs at full 2.5%. I ran it on the gate and filed the slate that clears.

Filed (props 57/58/59):

• BMY 2.5% (Health Care, new) — fills the open band (-1.7pp → ~11.3%). OCF $14.16B FY25 (SEC XBRL), fwd PE 9.1, beta 0.238, 4.5% yield. Low-vol cash-flow fill. Stop -15% rel; kill FY26 OCF <$11B; print 07-30.
• GIS 2.0% (Staples, new) — deepest dislocation on the sheet, 8.2x, 7.2% yield, beta -0.04, >35% off high. Paired with the PEP trim. Stop -15% rel; print 07-01.
• PEP 2.62%→1.3% — funds the Staples band-room for GIS; reallocating within the low-vol/cash-flow factor toward the cheaper name. Thesis on PEP intact, not a kill.

Beta verdict (my lane): slate clears clean as a unit — book beta 0.904, top-5 90.8%, no ETN move. GIS at 2.5% tips beta to 0.8998 (one bp under the 0.90 floor, vetoed) and only clears if ETN goes 2.36%→3.1% — a 75bp add on a 1.24-beta top detractor, reals at 2.20 cycle high (need <1.90 to add). That's the ETN add I killed at #44/#45. I won't manufacture beta room by leaning into the wrong factor. GIS stays 2.0% — which also right-sizes a starter into its 07-01 print (two ugly quarters behind it: -12.3%, -25% surprises).

Book to 9 active names. Triggers unchanged: OAS>350 trims ETN; reals<1.90+10yr<4.30 eases low-vol.

Tabled prop #53 (PEP resize 2.50%→3.00%) and killed it on my own discipline — same logic as the ETN kill.

PEP status: held 2.50%, last $141.92, only -1.83% since the $144.57 fill. It hasn't dislocated further, so there's no fresh entry edge versus where we already own it. Staples is already +1.7bps active and 1.6pp over SPY.

Why no add: a ~50bp top-up funded by an SPY trim doesn't move the real lever (84.7% dead SPY core, -214bps). It just leans the Staples tilt harder without buying any new selection alpha — same crowding objection I raised on a third low-vol leg. Gate clears (would_clear, no breaches) but cleared isn't a reason to file.

The call: carry PEP at 2.50%. Stop unchanged -15% rel (~37bps NAV); real kill is FY2026 OCF <$11B. No resize filed.

Next target: Health Care band (-1.7pp, zero active names) — Margaret's name to fill, I size and pair. Triggers unchanged: OAS>350 → trim ETN; reals<1.90 + 10yr<4.30 → eases low-vol.

Tabled prop #52 (ETN resize 2.45%→2.50%) and killed it on my own triggers.

ETN status: held 2.45%, last $395.94, -3.72% since entry — book's top detractor (-9.2bps inception, -13.7bps since last meeting on a -5.42% week). The proposed move is a ~5bp token top-up funded by an SPY trim. That's noise — it doesn't move active gross (the real lever, 84.7% dead SPY core).

Why no add: my eased-frame trigger is reals<1.90 + 10yr<4.30 to migrate ETN to the right side. We're at reals 2.11 (fresh cycle high) / 10yr 4.47 — dead wrong side. And VIX popped 15.4→21.5 in one session. Adding a 1.24-beta cyclical into a vol pop with rising reals is backwards.

The call: carry ETN as the beta-floor lever (keeps the book off the 0.90 floor), don't add. Stop on the held position stays -15% rel (~37bps NAV). No resize filed.

Triggers unchanged: OAS>350 → trim ETN; reals<1.90 + 10yr<4.30 → eases low-vol, migrates ETN right-side. The Health Care band (-1.7pp, zero active names) is the next target — Margaret's name to fill, I size and pair.

Ran the gate live on all three names circling. Funding is settled — cash at 0.10% floor, seventh session, anything bought trims SPY. Lever is active gross (84.7% dead core, -214bps).

GIS — real dislocation ($33.15, -36% off high, 8.1x, 7.4% fwd yield, beta -0.04) but gate clears it only at 1.0% (second Staples name on PEP trips 1.6x band). Plus fiscal-Q4 print 07-01, two ugly quarters behind it. Sub-conviction starter into earnings — pass. First name in the chamber when Staples opens (PEP resize/roll-off). Co-sponsor Margaret's conv-4 then.

ABBV — clears 2.5% but ran +9.3% in 18 sessions to $227. "Tape divorced from franchise" doesn't fit a name mid-rally. Margaret's $205-210 discipline is right; won't chase.

XLV — clears 2.5%, Health Care is the open band (-1.7pp, ZERO active names, room to 11%). But sector ETF = tilt, zero selection alpha. Selection is Margaret's lane per IPS. Won't file an index lean as slot-filler.

Why nothing from me: sponsored ETN+PEP last session, both red (ETN -3.7%); a third same-factor leg is crowding not diversifying. The open Health Care band is Margaret's to fill with a cash-flow-yield name she underwrites — I size and pair it when it comes.

Triggers: OAS>350 → trim ETN; reals<1.90 + 10yr<4.30 → eases low-vol, migrates ETN right-side.

Called the vote on PEP 2.5% (Staples, ~$25k, ~175 sh @ $142.54), funded by trimming SPY first per Ops sequencing (no fund-before-trim — sell SPY, then buy off proceeds). Gate re-checked live: would_clear=true, no breaches, inside the 0.5–3.5% band.

Case (settled): SEC FY2025 10-K via XBRL — rev $93.9B, OCF $12.1B held flat vs $12.5B prior while diluted EPS air-pocketed to $6.00 off $6.95. Market extrapolating an earnings dip into a cash engine that didn't move. Tape -8.8% MTD, fresh lows — buying weakness. Priya: textbook frame expression, low-vol on (reals 2.07 >2%, 10yr 4.46 above 4.30). Iris: ~25bps NAV on -10%, ~50bps on -20% stress; stop -15% rel (~37 bps).

Pair logic: ETN (beta 1.24, filled at $411.22 ~2.56%) lifts the book off the 0.90 beta floor; PEP (low-beta) anchors the defensive side — net ~beta-neutral while two sectors migrate out of the idle SPY core. Real kill is FY2026 OCF <$11B — thesis break, not price.

Voting order: Margaret, Daniel, Priya, Iris. Daniel AYE and filed. Book to 7 active names post-fill — campaign toward the 18-name floor holds.

Two filed for today's vote, both outside the full Financials sleeve, both funded from the idle 90% SPY block.

ETN — open 2.5%, Industrials (prop #50). My factor leg. The book is pinned at the 0.90 beta floor (CME 0.26 / V 0.78 / XOM 0.18, only SPGI >1). ETN beta 1.24 lifts the book off the floor AND migrates sector (Industrials -0.8pp underweight). Primary FY2025 SEC XBRL: $27.4B rev +10%, $4.09B NI, $10.45 EPS +10%, $4.47B OCF, float 393→388M. Tape $421.21, near 50d MA, ~3% off 52w high. Rich at 41x trailing / 31x fwd — owned openly; it's the only above-floor-beta quality name I can source. Stop -15% rel (~37 bps NAV); -20% stress ~50 bps.

PEP — open 2.5%, Staples (prop #51). Co-sponsoring Margaret. Cash-flow-yield + low-vol per Priya's frame. SEC FY2025: $93.9B rev, OCF $12.1B held flat while EPS sagged to $6.00. Tape $142.54, fresh lows, -8.8% MTD. Staples -0.6pp underweight. Stop -15% rel; wrong if FY2026 OCF <$11B.

Pair logic: PEP low-beta vs ETN high-beta — net book beta stays roughly neutral while two sectors migrate out of the SPY core. ~5pp new active share. Book to 7 active names post-fill. Financials stays full by design. Daniel votes AYE on both.

Roll on CME 2.5% open. Voting order: Margaret, Daniel, Priya, Iris. Ops abstains.

Case: rate-complex derivatives toll booth — fee per contract cleared, counter-cyclical, monetizes the bear-steepener Priya frames. FY2025 10-K (SEC XBRL): $6.52B rev (+14% YoY), $4.23B op inc (~65% margin), $11.16 EPS, $4.28B OCF; ignore the $198B asset gross-up (clearing collateral). Beta 0.26 — deepens the low-vol tilt alongside V 0.78 / SPGI 1.10. Name ran -8.5% over 10 sessions into the buy — buying weakness. Clears the live gate at 2.5% (would_clear=true, no breaches), funded out of the SPY block. Loss path per Iris: ~25 bps NAV on -10%, ~50 bps on -20% stress; stop -15% rel / ~37 bps.

Daniel votes AYE and files. Binding constraint from here is the Financials sector-vs-SPY band — V + CME ~5.5% active, sector to ~8% active vs SPY. Next legs come from other sectors. Campaign toward the 18-name floor continues.

Roll on V 3.0% open. Voting order: Margaret, Daniel, Priya, Iris. Ops abstains.

Case: VisaNet toll-booth, fee on volume, zero credit risk — top-left quality on Priya's late-cycle / real-rate frame. FY2025 10-K (SEC XBRL): $40.0B rev, ~60% op margin, $23.1B OCF on $20.1B NI (>100% conversion); +17% rev YoY; beta 0.784, low-vol pull alongside XOM/SPGI. Clears the live gate at 3.0% (would_clear=true, under 3.5% band), funded out of the ~95% SPY block — migration, not concentration. Loss path per Iris: ~30 bps NAV on -10%, ~60 bps on -20% stress; stop -15% rel / ~45 bps.

Daniel votes AYE and files. Binding constraint from here is the Financials sector-vs-SPY band (V+SPGI ~5.5% active), not the single-name gate.

Roll on SPGI 2.5% open. Voting order: Margaret, Daniel, Priya, Iris. Ops abstains.

Case: index/ratings/data toll-booth, top-left quality, cleanest single-name read on Priya's late-cycle / real-rate frame. Numbers reconciled across EODHD TTM-MRQ and FY2025 10-K. Beta 1.105 — only above-1 name on the board, carries the quality-compounder slot vs V/CME low-vol tilt. Loss bounded (~25 bps NAV on -10%, ~50 bps on -20% per Iris). Clears gate at 2.5%.

Daniel votes AYE and files. Watch as the book fills: financials sector band (V+CME+SPGI ~8% active) is the binding constraint, not the single-name gate.

07-09 VOTE #79 — GILD seats at last, β0.9141 with 141bps room. Approved my own leg.

Four sessions on the same wall; GOOGL-in/CME-out finally broke it. Gate clears clean, floor cushion real (141bps). Approved. Two things on the record: cash to ~93bps sub-floor (warn, cure next session from SPY grind); and I'm topping a winner into strength ($121→$135.50), not buying a dislocation — the book stays β-starved. Book 14/18. Next adds must be β≥1.15 quality on a pullback, not more low-vol ballast. This closes out the GILD pre-commitment I've carried since 06-18 — no faked beta, seated honestly behind GOOGL's β1.247.

07-09 GILD #79 — the wall finally fell. CME exit unlocks the pre-committed β0.33 leg.

GOOGL filled (70 sh @ $355.52, funded by SPY trim, now ~2.58%) and CME closed. That flipped the four-session GILD wall. The structural fact since 06-18: one β≥1.15 name could cure the floor OR carry GILD's β0.33 drag, not both. CME's β0.26 exit lifted the book to β0.9202 — 20bps cushion — so GILD 1.02%→2.0% now clears solo AND basket, zero breaches, beta lands 0.9141 (41bps above floor). No faked beta needed; the leg seats honestly at last.

On-frame: reals 2.30 fresh cycle high, low-vol ON (Priya). GILD = 39% op margin, ~$10B OCF, ROE 43%, fwd ~15x — quality ballast.

The one honest caveat I keep flagging: GILD ran $121→$135.50, near range highs. This is topping a winner into strength, not buying a dislocation — the opposite of the GOOGL/MSFT/GS dislocation entries. I take the seat anyway because the leg's been pre-committed since 06-18, the floor cushion is real, and the book stays β-starved (5 names β<0.4). But I'd rather the NEXT adds be β≥1.15 quality on a real pullback, not more low-vol crutch. Book now 14/18. Triggers carry: OAS>350 → XOM/FDX first cut; reals<1.90+10yr<4.30 → ease low-vol + ETN right-side.

07-09 RE-CUT — SPY leg #78 vetoed at ops (cap wall), re-funded GOOGL from CME close (#80/#81)

The SPY-cap wall finally bit at ops: trim to 68.1% leaves SPY at 70.70%, still over the 3.5% single-name band, so the gate reads it as a still-breaching line and vetoes — even though the trim REDUCES the breach (direction-aware clear held in check_basket_risk but ops applied the literal cap). Lesson banked: the passive SPY core cannot be shrunk under the cap in a single trim; SPY-funded adds will keep hitting this until the room treats the index core as a policy carve-out or grinds it down over many sessions.

The pivot was clean and actually better: fund GOOGL 2.5% from the CME CLOSE instead of the SPY trim. Live basket (GOOGL open + CME close): would_clear true, zero breaches, beta 0.9125→0.9132 (GOOGL β1.247 lifts the floor, CME β0.26 out helps), cash cures 1.71→4.02%, Comm Svcs 6.4→8.7% closes the -2.6pp gap, Financials 19.9→17.3% relieves the +6.9pp over. CME-close SOLO trips min-holdings (12 vs 18) — must travel as the basket to hold count at 13.

This converts my worst active detractor (CME -21.3bps, β0.26, -8.53% since entry, standing cut since 06-18) into a β1.247 quality compounder in an underweight sector. Upgrades a drag rather than shrinking the passive core — strictly better than the vetoed SPY structure. GILD's second β0.33 leg stays pre-committed; still no faked beta. Count holds 13/18. Triggers carry: OAS>350 → XOM/FDX first cut; reals<1.90+10yr<4.30 → ease low-vol + ETN right-side.

07-09 PROPOSE — co-sponsored GOOGL/SPY (#77/#78), filed GILD 2.0% (#79) as secondary

Backed Margaret's #19 in full — the campaign trade I've sponsored since FRAME: SPY 71.5→68.1 funds GOOGL 2.5%, 13→14 real count advance, Comm Svcs -2.6pp gap closed, passive→active. Gate: beta 0.9125→0.9103 (holds floor), cash cures to 2.59%, SPY cap reduced (direction-aware clear, same as my 07-06 MSFT pair). GOOGL is β1.247 quality on a real dislocation ($408→$330 06-26 washout→reclaimed $362, above 200d). Q2 07-22, clear today.

The interesting find: the 3-leg basket (GOOGL+SPY+GILD→2.0%) ALSO clears — GILD's pre-committed second β0.33 leg finally seats behind GOOGL's beta, beta lands 0.9042. But two honest weaknesses: (1) 42bps floor cushion is thin; (2) GILD ran $121→$136 this month, near range highs — I'd be topping a winner into strength, not buying a dislocation. So I filed it SECONDARY and told the room to drop it if they'd rather hold cushion or save GILD's carry for the CME recycle. Ranked conviction: GOOGL/SPY >> GILD. Didn't force CME this session — no vetted replacement on the pad, it travels paired only.

Discipline note: refused to fake the case on GILD. Beta at 0.9042 into a 10yr backed up to 4.55 / reals 2.30 fresh cycle high (Priya) is a real path-risk — the book stays β-starved and one soft tape re-breaks the floor. The right long-term fix is more β≥1.15 quality (GILD carries for the eventual CME→new-name swap), not more low-vol ballast stacked at the floor.

Triggers carry: OAS>350 → XOM/FDX first cut; reals<1.90+10yr<4.30 → ease low-vol + ETN right-side.

07-09 FRAME — 10th week, frame holds, reals to fresh cycle high 2.30

Book unchanged since 07-06 MSFT/SPY pair. 13/18, β0.9125 on floor, SPY still 71.5% = -109bps contribution / -18.6 active, the whole story. Active sleeve net positive (V+29.6, GIS+16.8, GILD+10.3, BMY+9.9). Campaign to 18 = convert index→active quality, grind SPY to low-60s.

Priya line that moved: reals 2.30 fresh cycle high (10yr 4.55, backed up), tighter squeeze not looser. Low-vol stays ON. Tell: VIX 16.9 near lows + OAS 2.67 compressed = complacency, not all-clear. WTI $69.60 — energy hedge deflating hard, XOM on watch.

Tilt I sponsor: quality + cash-flow-today over low-vol-crutch. Book already β-starved (5 names β<0.4) — need β≥1.15 quality, not more ballast. TMT still -6.3pp = biggest gap, want a compounder there funded from SPY. Financials +6.9pp tapped, CME worst detractor -21.3bps β0.26 = standing cut paired w/ new name. GILD 2nd leg pre-committed for the next high-beta unlock, no faked beta. Triggers carry: OAS>350 cyclical trim first; reals<1.90+10yr<4.30 ease low-vol + ETN right-side.

#71 VOTE 07-06 — reject GILD 1.02%→2.0% with the room, 4th session on the same wall. MSFT/SPY alone = beta 0.9059 (holds 0.90 floor); + GILD's β0.33 leg = 0.8996, floor breach, gate veto (Iris live, ops all-funding-ways). The structural fact unchanged since 06-25: one β≥1.15 name cures the floor OR carries a β0.33 leg — not both. GILD stays pre-committed for the NEXT high-beta quality name — no faked beta off the ETN into reals at 2.25. MSFT/SPY pair (#75/#76) is the campaign trade that matters this session; GILD carries at 1.02%. Triggers carry: OAS>350 → XOM/FDX first cut; reals<1.90+10yr<4.30 → ease low-vol + ETN right-side.

07-06 PROPOSE — MSFT 2.5%, funded from SPY trim to 70.7%. The campaign trade: index dollars → active quality in the TMT gap.

Finally a name that does everything the campaign needs at once. MSFT 2.5% open, funded by trimming SPY 73.9%→70.7% (−3.19pp). Basket verified live (check_basket_risk): beta 0.9105→0.9059 (holds floor w/ cushion), cash 1.66%→2.36% (CURES the sub-floor breach same trade), SPY-cap breach REDUCED (only flagged line, direction-aware improvement), 12→13 names, TMT 22.9→24.4 (closes the −8.1pp active gap I named in FRAME as our biggest tilt cost).

WHY MSFT / WHY NOW: ran $460 (06-01) → $352.83 intraday low (06-25), −23% off the run-up peak, −29% off the $551 52w high. Bounced to $390 (07-02), reclaimed off the low, higher low held — stabilizing, not a knife. Tape-divorced-from-franchise on a top-tier compounder. FY25 (SEC XBRL 10-K): rev $281.7B (+15%), op inc $128.5B (46% margin), NI $101.8B, dil EPS $13.64, OCF $136B, ROE ~30%. Fwd 20x, β1.13. Beat every quarter (+4.4/+31.6/+1.6/+8). Prints fiscal Q4 07-29 — 23d out, well outside the T+1 freeze. Buying quality on a dislocation WITH runway, not a binary.

The legs MUST travel together: SPY trim ALONE breaks the beta floor (0.875, veto) — MSFT's β1.13 dollars are the offsetting beta that hold 0.90. MSFT solo clears but doesn't cure the cash floor. Only the pair does both.

STOP on MSFT: Q4 07-29 miss on a franchise line (Azure/cloud rev decel below ~20%, op margin compression), or −15% rel. This rhymes with buying the 2022 mega-cap-software washout into a stabilizing tape — the dislocation is the entry, the franchise isn't cracked.

Triggers carry: OAS>350 → XOM/FDX first cut; reals<1.90+10yr<4.30 → ease low-vol + ETN right-side.

07-06 FRAME — the SPY albatross is the whole story

Book: NAV $990.4K, 12/18 names, β0.9105 on the 0.90 floor, cash 1.67% (~$16.5k) sub-floor + un-swept. YTD excess -1064bps, gap to target -1564.

The real read from attribution (since-inception): SPY at 73.9% weight = -115bps contribution, -19.4bps ACTIVE. That giant passive core is why we track SPY-minus-costs and can't open a +500bps gap. Active names are NET POSITIVE: V +43.6, GIS +24.0, BMY +10.6, SPGI +9.6, GILD +7.0. The stock-picking works; there's just not enough of it. Only 26% of NAV is active. To beat SPY by 500 we must convert SPY-core into active names — that's the campaign to 18.

TILT I sponsor (riding Priya 07-06: late-cycle / re-accel inflation / reals 2.25 restrictive / OAS 2.75 complacent / VIX 15.8 collapsed):

• Gross ~100% (long-only, cash residual to 2-3%). Grind SPY 73.9%→low-60s over the campaign, funding active adds.
• Factor: quality + cash-flow-today OVER low-vol-as-a-crutch. Low-vol stays ON per reals, but our book is already β-starved (CME/GILD/XOM/GIS/PEP/BMY all β<0.4). We need β≥1.15 quality names to seat, not more ballast.
• Sectors: Financials 20.4% (1.6x cap — tapped, no more), TMT UNDERWEIGHT 22.9 vs 31 SPY (-8.1pp — the biggest active tilt and it's costing us -6bps active but capping upside; late-cycle I hold it but a quality-compounder TMT name is the gap). Energy 4.8% keep as inflation hedge but XOM -13bps active is on watch (OAS>350 → first cut). Staples overweight working (+24.4 active) — keep.
• CME still worst active detractor -22.3bps, β0.26 dead money — standing cut, but only travels PAIRED with a new name to hold the 18-floor.

Where I want the book to MOVE: fewer index dollars, more active quality cyclicals. VIX 15.8 = cheap to add beta if a dislocation appears; complacency is the setup, not all-clear.

#71 VOTE 07-02 — approve #70, my own GS 2.5% standalone restructure, carried by the room. CME close died on the 18-name floor (11→10), killed the funding leg; GS rides cash. Verified live twice (mine + Iris): would_clear TRUE, zero breaches, beta 0.9058→0.9127 lifts off the 0.90 floor on real GS β1.29 dollars, 11→12 real headcount advance, top-5 85.1%. Tradeoff owned: quality-cyclical add + beta lift + genuine 12th name, but does NOT cure the 1.63% un-swept cash floor and leaves CME β0.26/-37.7bps worst-detractor in the book. Both wait for a session where CME can pair a second name. GS STOP: Q2 07-14, franchise-line miss / ROE<11% / -15% rel. GILD pre-committed for the next β≥1.15 name. Triggers carry: OAS>350 → XOM/FDX first cut; reals<1.90+10yr<4.30 → ease low-vol + ETN right-side. Campaign resumes toward 18 next session with a clean SGOV residual to fund from.

07-02 late — GS restructured to standalone after CME close vetoed on the 18-floor

#69's CME close VETOED — minimum holdings, 11→10 under the 18-name floor. Confirmed exactly what I flagged: CME only travels PAIRED with a second new name (to hold/advance count), never naked. Tonight we had no second name, so the close dies and GS can't fund off it.

Restructured to what clears: GS 2.5% standalone. Verified live — check_basket_risk solo → would_clear TRUE, zero breaches, beta 0.9058→0.9127 (lifts off 0.90 floor cleanly), 11→12 names (real headcount advance), top-5 85.1%. Engine funds GS off the SPY sweep so cash stays 1.63% — the sub-floor breach is NOT cured tonight, uncured and owned. Tradeoff on the record: I get the quality-cyclical add + beta lift + a genuine 12th name, but I do NOT cure the cash floor and I leave the CME β0.26/-37.7bps worst-detractor in the book. Both wait for a session where CME can pair a second name.

GS why-now confirmed live: $1,019.61 on 07-01, held $1,011–$1,020 all week off the 06-26 dislocation (~9% off $1,125 high), no run-back-up, no franchise crack. Tape-divorced-from-franchise, the setup I held out for since 06-18. STOP: Q2 07-14 (12d, outside freeze), franchise-line miss / ROE<11% / -15% rel. Triggers carry: OAS>350 → XOM/FDX first cut; reals<1.90+10yr<4.30 → ease low-vol + ETN right-side. GILD stays pre-committed for the next β≥1.15 name — no faked beta.